Medgenics Inc

Type: Company
Name: Medgenics Inc
First reported Jul 24 2014 - Updated Jul 24 2014 - 1 reports

TransCelerate Selects Cognizant to Develop a Clinical Trials Collaboration Platform

--The Shared Investigator Platform, Built as an Industry Utility, Will Help Accelerate the Development of New MedicinesTEANECK, New Jersey, July 24, 2014 /PRNewswire/ -- Cognizant (NASDAQ: CTSH) today announced that it has been selected by TransCelerate ... [Published ADVFN India - Jul 24 2014]
First reported Jul 18 2014 - Updated Jul 18 2014 - 1 reports

MEDGENICS : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)

Item 5.02 Departure of Directors or Certain Officers; Election of Directors;Appointment of Certain Officers; Compensatory Arrangements of CertainOfficers.On July 15, 2014 , Medgenics, Inc. (the "Company") and its wholly ownedsubsidiary, Medgenics Medical ... [Published 4 Traders - Jul 18 2014]
First reported Jul 17 2014 - Updated Jul 17 2014 - 1 reports

FDA Confirms Endpoints of Androxal Study; Paladin Labs Announces the Canadian Launch of Veregen®

Below is a look at some of the headlines for companies that made news in the healthcare sector on July 16, 2014.Repros Therapeutics Inc.® (Nasdaq: RPRX) today announced it has received additional guidance from the FDA regarding primary endpoints for the ... [Published BioMedReports - Jul 17 2014]
First reported Jul 16 2014 - Updated Jul 16 2014 - 1 reports

Medgenics Reports Second Quarter Financial Results

(GLOBE NEWSWIRE) -- Medgenics, Inc. (NYSE MKT:MDGN) (the Company), the developer of a novel platform technology for the sustained production and delivery of therapeutic proteins in patients using ex vivo gene therapy and their own tissue for the treatment ... [Published Town Hall - Jul 16 2014]
First reported Jun 23 2014 - Updated Jun 23 2014 - 1 reports

TransCelerate BioPharma Inc. Launches Two New Global Initiatives, Names Two New Board Members

/PRNewswire/ -- TransCelerate BioPharma Inc.  ("TransCelerate") is launching two new global initiatives enabled by broad participation and collaboration across the global research and development (R&D) community: develop a position on the best and most ... [Published Fierce Biotech IT - Jun 23 2014]

Quotes

...and Shared Investigator Platform Leader, TransCelerate.  "The Shared Investigator Platform will benefit sites by simplifying processes, and reducing time and effort spent on standard study activities. TransCelerate conducted a comprehensive selection process for this initiative and Cognizant provided the key attributes required for this unique partnership. We anticipate an overall improvement in the quality of studies and the data generated from the Shared Investigator Platform initiative."
"We are pleased to announce the launch of Veregen® in Canada," said Mark Beaudet, President of Paladin Labs Inc. "Sexually transmitted infections (STIs) such as external genital warts can cause tremendous psychological stress(3). Canadians who suffer from external genital warts now have a new, non-invasive and effective topical treatment option with a demonstrated tolerability profile."
...statements are sometimes identified by their use of the terms and phrases such as "estimate," "project," "intend," "forecast," "anticipate," "plan, "planning, "expect," "believe," "will," "will likely," "should," "could," "would," "may" or the negative of such terms and other comparable terminology. All such forward-looking statements are based on current expectations and are subject to risks and uncertainties. Should any of these risks or uncertainties materialize, or should any of the Company's assumptions prove incorrect, actual results may differ materially from those included within these forward-looking statements. Accordingly, no undue reliance should be placed on these forward-looking statements, which speak only as of the date made. The Company expressly disclaims any obligation or undertaking to disseminate any updates or revisions to any forward-looking statements contained herein to reflect any change in the Company's expectations with regard thereto or any change in events, conditions or circumstances on which any such statements are based. As a result of these factors, the events described in the forward-looking statements contained in this release may not occur."
...new projects, we continue to tackle areas of R&D inefficiency and common need," said Dalvir Gill, PhD, Chief Executive Officer of TransCelerate. "The Clinical Data Transparency project is an excellent example of TransCelerate member companies working together in response to a common need rather than each addressing it individually. For this project, we will work closely with other stakeholders like EFPIA and PhRMA to ensure a coordinated effort. Overall, we are making significant progress with all our ongoing projects and we will continue to focus on delivering practical and actionable solutions to the clinical trials community."

More Content

All (10) | News (8) | Reports (0) | Blogs (0) | Audio/Video (0) | Fact Sheets (0) | Press Releases (2)
sort by: Date | Relevance
TransCelerate Selects Cognizant to Develop a Cl... [Published ADVFN India - Jul 24 2014]
MEDGENICS : Change in Directors or Principal Of... [Published 4 Traders - Jul 18 2014]
FDA Confirms Endpoints of Androxal Study; Palad... [Published BioMedReports - Jul 17 2014]
Medgenics Reports Second Quarter Financial Results [Published Town Hall - Jul 16 2014]
TransCelerate BioPharma Inc. Launches Two New G... [Published Fierce Biotech IT - Jun 23 2014]
Faruqi & Faruqi, LLP Launches An Investigation ... [Published Financial Services - Mar 14 2014]
Medgenics, Inc. to Present at the 26th Annual R... [Published GlobeNewswire: Acquisitions News - Mar 05 2014]
Directors Dealings [Published TrustNet - Nov 15 2013]
Medgenics net losses rise [Published TrustNet - Nov 07 2013]
Medgenics to present poster at ESGCT Congress [Published TrustNet - Oct 23 2013]
1
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Press Releases

sort by: Date | Relevance
Faruqi & Faruqi, LLP Launches An Investigation ... [Published Financial Services - Mar 14 2014]
Medgenics, Inc. to Present at the 26th Annual R... [Published GlobeNewswire: Acquisitions News - Mar 05 2014]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.